Fisher D A, Schoen E J, La Franchi S, Mandel S H, Nelson J C, Carlton E I, Goshi J H
Quest Diagnostics, Inc - Nichols Institute, San Juan Capistrano, California 92690-6130, USA.
J Clin Endocrinol Metab. 2000 Aug;85(8):2722-7. doi: 10.1210/jcem.85.8.6718.
Measurements of serum concentrations of free T4, T3, TSH, and thyroglobulin (Tg) were conducted in 42 infants (2-9 months of age) detected and treated through the Northwest Newborn Regional Screening Program and 63 children and adolescents (1-18 yr of age) with congenital hypothyroidism (CH) detected and managed in the Northern California Kaiser Permanente Medical Care Program. Normal feedback control axis data were developed by Quest Diagnostics, Inc. - Nichols Institute Diagnostics and Loma Linda University, from free T4 and TSH measurements in 589 healthy subjects, 2 months to 54 yr of age; 83 untreated hypothyroid patients; and 116 untreated hyperthyroid patients. Twenty-four of the 42 CH infants and 57 of the 63 CH children manifested serum TSH concentrations appropriate for the measured free T4 level. In the remaining 18 infants and 6 children, serum free T4 values were increased 0.2-1.4 ng/dL (2.6-18.0 pmol/L) for the prevailing TSH level, suggesting a state of mild to moderate pituitary-thyroid hormone resistance. In the treated children, the mean T3 concentration was lower (by 32%, 102 vs. 150 ng/dL; 1.57 vs. 2.31 nmol/L) than in normal children, in agreement with earlier data in hypothyroid adults treated with exogenous T4. Serum Tg concentrations were normal or elevated in 90% of the 19 children with ectopic glands and 93% of 27 children with eutopic glands in whom measurements were available. There was a positive correlation between serum TSH and Tg concentrations (P < 0.001), suggesting significant endogenous thyroid hormone production in these children. Our results suggest that the majority of infants and children with CH have a normal hypothalamic-pituitary-thyroid negative feedback control axis during treatment and that the measurement of serum TSH is a useful marker complementing the free T4 measurement in the management of children with CH. A minority have variable pituitary-thyroid hormone resistance, with relatively elevated serum TSH levels for their prevailing serum free T4 concentration. The prevalence of resistance is greater (43%) in young infants (< 1 yr of age) than in older children (10%), indicating that, in most children, the resistance improves with age.
对通过西北新生儿区域筛查项目检测并治疗的42名婴儿(2至9个月大)以及在北加利福尼亚凯撒永久医疗项目中检测并管理的63名先天性甲状腺功能减退症(CH)儿童及青少年(1至18岁)进行了血清游离T4、T3、促甲状腺激素(TSH)和甲状腺球蛋白(Tg)浓度的测定。正常反馈控制轴数据由奎斯特诊断公司 - 尼科尔斯研究所诊断部和洛马林达大学根据589名2个月至54岁健康受试者、83名未经治疗的甲状腺功能减退患者以及116名未经治疗的甲状腺功能亢进患者的游离T4和TSH测量值得出。42名CH婴儿中有24名以及63名CH儿童中有57名的血清TSH浓度与所测游离T4水平相符。在其余18名婴儿和6名儿童中,对于当前的TSH水平,血清游离T4值升高了0.2至1.4 ng/dL(2.6至18.0 pmol/L),提示存在轻度至中度垂体 - 甲状腺激素抵抗状态。在接受治疗的儿童中,平均T3浓度低于正常儿童(降低了32%,分别为102与150 ng/dL;1.57与2.31 nmol/L),这与早期关于接受外源性T4治疗的甲状腺功能减退成人的数据一致。在可进行测量的19名异位甲状腺患儿和27名正常位置甲状腺患儿中,分别有90%和93%的患儿血清Tg浓度正常或升高。血清TSH与Tg浓度之间存在正相关(P < 0.001),提示这些儿童存在显著的内源性甲状腺激素产生。我们的结果表明,大多数CH患儿在治疗期间下丘脑 - 垂体 - 甲状腺负反馈控制轴正常,并且血清TSH测量是CH患儿管理中补充游离T4测量的有用指标。少数患儿存在可变的垂体 - 甲状腺激素抵抗,其当前血清游离T4浓度对应的血清TSH水平相对升高。年龄较小婴儿(<1岁)中抵抗的患病率(43%)高于年龄较大儿童(10%),这表明在大多数儿童中,抵抗会随着年龄增长而改善。